These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23746720)

  • 1. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013;63:450-8.
    Kim KH; Rha KH
    Eur Urol; 2013 Sep; 64(3):e55-6. PubMed ID: 23746720
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.
    van der Poel HG; Buckle T; Valdes Olmos R
    Eur Urol; 2013 Feb; 63(2):e20. PubMed ID: 23153744
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Kwang Hyun Kim and Koon Ho Rha's letter to the editor Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013;63:450-8.
    Tosco L; Van den Bergh L; Joniau S
    Eur Urol; 2013 Sep; 64(3):e57-8. PubMed ID: 23769590
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Henk G. van der Poel, Tessa Buckle and Renato Valdes Olmos' letter to the editor re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.
    Joniau S; Van den Bergh L
    Eur Urol; 2013 Feb; 63(2):e21-2. PubMed ID: 23149147
    [No Abstract]   [Full Text] [Related]  

  • 5. Pelvic lymph node dissection in prostate cancer: the mystery is taking shape.
    Briganti A; Suardi N; Gallina A; Abdollah F; Montorsi F
    Eur Urol; 2013 Mar; 63(3):459-61. PubMed ID: 22939386
    [No Abstract]   [Full Text] [Related]  

  • 6. Mapping of pelvic lymph node metastases in prostate cancer.
    Joniau S; Van den Bergh L; Lerut E; Deroose CM; Haustermans K; Oyen R; Budiharto T; Ameye F; Bogaerts K; Van Poppel H
    Eur Urol; 2013 Mar; 63(3):450-8. PubMed ID: 22795517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic drainage in prostate carcinoma assessed by lymphoscintigraphy and SPECT/CT: its importance for the sentinel node procedure.
    de Bonilla-Damiá A; Roberto Brouwer O; Meinhardt W; Valdés-Olmos RA
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):66-70. PubMed ID: 22055110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.
    Zhou X; Han X
    Eur Urol; 2019 Jul; 76(1):e15. PubMed ID: 30948226
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.
    Valerio M; Emberton M; Ahmed HU
    Eur Urol; 2019 Feb; 75(2):e21-e22. PubMed ID: 30224194
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.
    Van den Broeck T; Mottet N; Lam T
    Eur Urol; 2019 Jul; 76(1):e16. PubMed ID: 30967298
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019;76:871.
    Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Galosi AB; Montorsi F; Montironi R
    Eur Urol; 2020 May; 77(5):e122-e127. PubMed ID: 32089357
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767-8.
    Godtman RA; Stranne J; Hugosson J
    Eur Urol; 2016 Nov; 70(5):769-770. PubMed ID: 27210462
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263-82.
    von Eyben FE
    Eur Urol; 2021 Jun; 79(6):e176. PubMed ID: 33712301
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871.
    Sighinolfi MC; Rocco B
    Eur Urol; 2020 May; 77(5):e128-e129. PubMed ID: 32067794
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Steven Joniau, Alberto Briganti, Paolo Gontero, et al. Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study. Eur Urol 2015;67:157-64.
    Sundi D; Schaeffer EM; Ross AE
    Eur Urol; 2015 Jul; 68(1):e11-2. PubMed ID: 25846751
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62: Comorbidity Measurement in Patients with Prostate Cancer.
    Froehner M; Koch R; Graefen M
    Eur Urol; 2021 May; 79(5):e138. PubMed ID: 33612374
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Gaëtan Devos, Gert De Meerleer, Steven Joniau. Have We Entered the Era of Imaging Before Salvage Treatment for Recurrent Prostate Cancer? Eur Urol 2019;76:265-7.
    De Bruycker A; Fonteyne V; Ost P
    Eur Urol; 2019 Nov; 76(5):e147-e148. PubMed ID: 31300235
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Gaëtan Devos, Gert De Meerleer, Steven Joniau. Have We Entered the Era of Imaging Before Salvage Treatment for Recurrent Prostate Cancer? Eur Urol 2019;76:265-7.
    Dirix PR; Dal Pra A; Wiegel T
    Eur Urol; 2019 Nov; 76(5):e148-e149. PubMed ID: 31300233
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Michael Froehner, Rainer Koch, and Markus Graefen's Letter to the Editor re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62. Comorbidity Measurement in Patients with Prostate Cancer.
    van den Bergh RCN; O'Hanlon S; Cornford P; Mottet N;
    Eur Urol; 2021 May; 79(5):e139-e140. PubMed ID: 33608157
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Chao-Yu Hsu, Steven Joniau, Raymond Oyen et al. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur urol 2007;51:121-9.
    Nickers P; Lartigau E
    Eur Urol; 2007 Aug; 52(2):612. PubMed ID: 17399888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.